![Charmaine Gittleson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charmaine Gittleson
Chairman at
PERCHERON THERAPEUTICS LIMITED
Net worth: 8 870 $ as of 31/08/2026
Profile
Dr. Charmaine Gittleson, MD, is an Independent Non-Executive Director at Polynovo Ltd. and a Non-Executive Chairman at Percheron Therapeutics Ltd. She is on the Board of Directors at Imugene Ltd., Polynovo Ltd. and George Medicines Pty Ltd. Dr. Gittleson was previously employed as a Chairman by Patrys Ltd. and a Chief Medical Officer by CSL Ltd. She received her undergraduate degree from the University of the Witwatersrand.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2024 | 2,464,000 ( 0.16% ) | 8 870 $ | 31/08/2026 |
Charmaine Gittleson active positions
| Companies | Position | Start |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Chairman | - |
| POLYNOVO LIMITED | Director/Board Member | 01/04/2026 |
| IMUGENE LIMITED | Director/Board Member | 30/06/2026 |
Former positions of Charmaine Gittleson
| Companies | Position | End |
|---|---|---|
| PATRYS LIMITED | Chairman | 17/06/2025 |
| CSL LIMITED | Chief Tech/Sci/R&D Officer | - |
Training of Charmaine Gittleson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Polynovo Ltd.
 Polynovo Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Charmaine Gittleson
